Related Experiment Video

Updated: Jun 15, 2025

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.3K

Regenerating the ailing heart: Stem cell therapies for hypoplastic left heart syndrome

Udit Choubey1, Varsha Srinivas2, Yash Vardhan Trivedi3

  • 1Department of General Surgery, Shyam Shah Medical College, Rewa, Madhya Pradesh, India.

Annals of Pediatric Cardiology
|August 26, 2024
PubMed

Insights

Stem cell therapy shows promise for hypoplastic left heart syndrome (HLHS), a severe congenital heart defect. Early intervention with stem cells may improve heart function and reduce mortality in HLHS patients.

Area of Science:

  • Regenerative Medicine
  • Pediatric Cardiology
  • Congenital Heart Disease Research

Background:

  • Hypoplastic left heart syndrome (HLHS) is a critical congenital heart defect (CHD) involving underdeveloped left cardiac structures.
  • Current treatments like surgical palliation or heart transplant have limitations, with significant long-term morbidity and mortality.
  • Advancements in stem cell therapy offer a potential new avenue for managing HLHS.

Purpose of the Study:

  • To review the potential of stem cell-based therapies as an adjunctive treatment for HLHS.
  • To explore diverse stem cell origins and administration methods in HLHS treatment.
  • To highlight the importance of early intervention in pediatric stem cell therapy for HLHS.

Main Methods:

  • Review of current literature on stem cell therapy applications in HLHS.
  • Analysis of clinical trial data regarding safety and efficacy of stem cell treatments.
  • Exploration of stem cell signaling in developing myocardium.

Main Results:

  • Stem cell therapy has demonstrated safety and potential benefits in clinical trials for HLHS.
  • Observed benefits include improved ventricular function and reduced heart failure.
  • Younger myocardial tissue appears more responsive to stem cell interventions.

Conclusions:

  • Stem cell therapy presents a promising adjunctive approach for improving outcomes in HLHS patients.
  • Early application of stem cell therapy may be crucial for maximizing benefits.
  • Further research into stem cell therapies could significantly impact HLHS management.

Keywords:
Hypoplastic left heart syndromestem-cell therapyuni-ventricular pathology

More Related Videos

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

6.9K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

7.7K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K